These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 2872117)
41. Adverse events following DTP immunization in Maryland, 1987. Siddiqui MA; Lin FY; Trostel B; Israel E; Dwyer DM Md Med J; 1989 Jul; 38(7):556-9. PubMed ID: 2787465 [TBL] [Abstract][Full Text] [Related]
42. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine. Panpitpat C; Thisyakorn U; Chotpitayasunondh T; Fürer E; Que JU; Hasler T; Cryz SJ Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736 [TBL] [Abstract][Full Text] [Related]
43. An open study evaluating the reactogenicity and immunogenicity of a DTP vaccine containing an acellular pertussis component in four to six year old children. Lewis K; Cherry JD; Baraff LJ; Robinson RG; Dudenhoeffer FE; Holroyd HJ; Baker LR; Farchione SL; Gurwith M; Vernon S Dev Biol Stand; 1985; 61():563-9. PubMed ID: 2872132 [TBL] [Abstract][Full Text] [Related]
44. Use of a combined DTP-polio vaccine in a reduced schedule. Swartz TA; Roumiantzeff M; Peyron L; Stopler T; Drucker J; Epstein I; Leitner L; Goldblum N Dev Biol Stand; 1986; 65():159-66. PubMed ID: 2881820 [TBL] [Abstract][Full Text] [Related]
45. Adverse reactions and serologic response to a booster dose of acellular pertussis vaccine in children immunized with acellular or whole-cell vaccine as infants. Blennow M; Granström M Pediatrics; 1989 Jul; 84(1):62-7. PubMed ID: 2544850 [TBL] [Abstract][Full Text] [Related]
46. Differences in reactogenicity and antigenicity of acellular and standard pertussis vaccines combined with diphtheria and tetanus in infants. Anderson EL; Belshe RB; Bartram J J Infect Dis; 1988 Apr; 157(4):731-7. PubMed ID: 2894399 [TBL] [Abstract][Full Text] [Related]
47. Response of infants to Haemophilus influenzae type b polysaccharide and diphtheria-tetanus-pertussis vaccines in combination. Lepow ML; Peter G; Glode MP; Daum RS; Calnen G; Knight KM; Mayer D; Kuo JS; Lui NS J Infect Dis; 1984 Jun; 149(6):950-5. PubMed ID: 6376656 [TBL] [Abstract][Full Text] [Related]
48. [Comparative immunologic effectiveness of variants of the DTP vaccine]. Baeva EA; Selezneva TS; Rezepov FF; Chebotareva SV; El'nitskaia EA Zh Mikrobiol Epidemiol Immunobiol; 1986 Oct; (10):50-2. PubMed ID: 2879402 [TBL] [Abstract][Full Text] [Related]
49. Two injections of diphtheria-tetanus-pertussis-polio vaccine as the backbone of a simplified immunization schedule in developing countries. Cohen H; Nagel J Rev Infect Dis; 1984; 6 Suppl 2():S350-1. PubMed ID: 6610910 [TBL] [Abstract][Full Text] [Related]
50. Two trials of an acellular DTP vaccine in comparison with a whole-cell DTP vaccine in infants: evaluation of two PT doses and two vaccination schedules. Just M; Kanra G; Bogaerts H; Berger R; Ceyhan M; Pêtre J Dev Biol Stand; 1991; 73():275-83. PubMed ID: 1778319 [TBL] [Abstract][Full Text] [Related]
51. Acellular pertussis vaccination of 2-month-old infants in the United States. Pichichero ME; Francis AB; Blatter MM; Reisinger KS; Green JL; Marsocci SM; Disney FA Pediatrics; 1992 May; 89(5 Pt 1):882-7. PubMed ID: 1579399 [TBL] [Abstract][Full Text] [Related]
52. A double-blind study comparing an acellular pertussis-component DTP vaccine with a whole-cell pertussis-component DTP vaccine in 18-month-old children. Lewis K; Cherry JD; Holroyd HJ; Baker LR; Dudenhoeffer FE; Robinson RG Am J Dis Child; 1986 Sep; 140(9):872-6. PubMed ID: 2874738 [TBL] [Abstract][Full Text] [Related]
53. Severe reactions associated with diphtheria-tetanus-pertussis vaccine: detailed study of children with seizures, hypotonic-hyporesponsive episodes, high fevers, and persistent crying. Blumberg DA; Lewis K; Mink CM; Christenson PD; Chatfield P; Cherry JD Pediatrics; 1993 Jun; 91(6):1158-65. PubMed ID: 8502521 [TBL] [Abstract][Full Text] [Related]
54. The dose of diphtheria toxoid in combined vaccines and their use in children. Christensen PA; Pollak O; Carson S S Afr Med J; 1980 Apr; 57(17):689-92. PubMed ID: 7403998 [TBL] [Abstract][Full Text] [Related]
55. Longitudinal study of adverse reactions following diphtheria-tetanus-pertussis vaccine in infancy. Long SS; Deforest A; Smith DG; Lazaro C; Wassilak GF Pediatrics; 1990 Mar; 85(3):294-302. PubMed ID: 2304782 [TBL] [Abstract][Full Text] [Related]
56. Leads from the MMWR. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures. JAMA; 1985 Aug 23-30; 254(8):1009-11, 1014-6. PubMed ID: 3874970 [No Abstract] [Full Text] [Related]
57. Response of preterm infants to diphtheria-tetanus-pertussis immunizations. Bernbaum JC; Daft A; Anolik R; Samuelson J; Barkin R; Douglas S; Polin R J Pediatr; 1985 Aug; 107(2):184-8. PubMed ID: 3874942 [TBL] [Abstract][Full Text] [Related]
58. Clinical reactions and immunogenicity of the BIKEN acellular diphtheria and tetanus toxoids and pertussis vaccine in 4- through 6-year-old US children. Bernstein HH; Rothstein EP; Pichichero ME; Francis AB; Kovel AJ; Disney FA; Green JL; Marsocci SM; Lynd AM; Wood GC Am J Dis Child; 1992 May; 146(5):556-9. PubMed ID: 1621656 [TBL] [Abstract][Full Text] [Related]
59. Pertussis and the pertussis vaccine. McKercher SW S D J Med; 1986 Jan; 39(1):5-11. PubMed ID: 3484836 [No Abstract] [Full Text] [Related]
60. Leads from the MMWR. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures. JAMA; 1985 Aug; 254(7):895-7, 900. PubMed ID: 3874969 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]